Evidence map›Paper›PMID 40166799›Full record

ArticleCureus2025

Outcomes of Two-Stage Autograft Acetabular Reconstruction for Hip Replacement in Young Patients: A Series of 13 Cases.

Muhamad Rashidee Ab Rashid, Mohd Yusof Ibrahim, Mohammad Nazir Hassan

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Muhamad Rashidee Ab RashidOrthopedics Department, Hospital Raja Perempuan Zainab II, Kota Bharu, MYS.
Mohd Yusof IbrahimOrthopedics Department, Hospital Raja Perempuan Zainab II, Kota Bharu, MYS.
Mohammad Nazir HassanOrthopedics Department, Hospital Raja Perempuan Zainab II, Kota Bharu, MYS.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Managing complex hip arthritis in young patients poses significant challenges due to the critical need to preserve bone stock for potential future surgical interventions. Two-stage reconstruction can preserve bone, restore limb length, and address acetabular defects to achieve optimal functional outcomes and facilitate future revisions. Structural autografts offer the dual advantages of reduced infection risk and enhanced initial stability. This study evaluates the surgical outcomes of two-stage autograft reconstruction in the management of young patients with acetabular defects. This case series reports our experience using a two-stage structural autograft approach for acetabular defects in total hip replacement. In the first stage, the acetabular defect is reconstructed using a femoral head autograft, followed by a second-stage hip replacement after eight weeks. A total of 13 patients underwent this surgery, with a mean age of 35 years. Patients were followed up for an average of five years. Good press-fit stability was achieved in all cases. Follow-up plain radiographs showed excellent trabecular bridging between the graft and host bone, with no evidence of graft resorption or acetabular cup loosening. All patients demonstrated good functional outcomes, with no complications such as non-union, infection, or aseptic loosening. Only one patient had sciatic nerve palsy which resolved spontaneously. This technique is an excellent option for treating young patients with sizable acetabular defects. It effectively restores bone stock, provides essential biological stability, and facilitates future revision surgery when necessary.

Indexed as

acetabular defect reconstructionarthroplastyautografthip replacementlimb length discrepancyyoung patients

Identifiers

PMID40166799
PMCPMC11957849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.